INISOTCIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
RADNOSTIX INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-6.00%)
Close on Oct 19, 2026
- Market cap
- $24.87M
- P/E (TTM)
- –
- Dividend yield
- –
RADNOSTIX INC revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theranostics Products [Member] | $6.84M | $8.01M | $6.84M | $6.05M | – | – | – | – | – | – | 52.3% | -14.6% |
| Calibration & Reference Products [Member] | $4.25M | $3.52M | – | – | – | – | – | – | – | – | 32.5% | +20.7% |
| Cobalt Products [Member] | $1.75M | $2.37M | $1.04M | $1.16M | $1.35M | $1.23M | $846.40K | $2.04M | $507.90K | – | 13.4% | -25.9% |
| Medical Device Products [Member] | $228.95K | $8.66K | $0 | – | – | – | – | – | – | – | 1.8% | +2544.7% |
| Fluorine Products [Member] | $0 | $0 | $0 | $0 | $29.78K | $178.35K | $160.50K | $0 | $0 | – | 0.0% | – |
| Radiochemical Products [Member] | – | – | – | $6.05M | $4.28M | $4.07M | $2.85M | $2.26M | $2.32M | – | – | – |
| Radiological Services | – | – | – | – | $160.16K | $216.14K | $1.17M | $2.27M | $1.36M | – | – | – |
| Nuclear Medicine Products [Member] | – | $3.52M | $4.39M | $3.98M | $4.00M | $3.67M | $3.93M | $3.79M | $3.23M | – | – | – |
| Nuclear Medicine Standards | – | – | – | – | – | $3.67M | $3.93M | $3.79M | – | – | – | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | – | – | – | – | – | – | – | $8.26M | $7.13M | – | – | – |
| Non-US [Member] | – | – | $2.24M | $1.53M | $1.46M | $1.28M | $1.69M | $2.11M | $285.87K | – | – | – |
| United States | – | – | $10.02M | $9.65M | $8.20M | $8.08M | $7.26M | $8.26M | – | – | – | – |
From the segment and revenue-disaggregation notes of Radnostix's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.